Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, v. 37, n. 3-4, p. 486-491, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2009.04.006. Acesso em: 22 ago. 2024.APA
Rodrigues, A. C., Curi, R., Hirata, M. H., & Hirata, R. D. C. (2009). Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, 37( 3-4), 486-491. doi:10.1016/j.ejps.2009.04.006NLM
Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006Vancouver
Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006